STEVENSON, Md., April 04, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of BofI Holding, Inc. (Nasdaq:BOFI) (“BofI” or the “Company”) securities during the period between April 28, 2016 and March 30, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until June 2, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in BofI securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that BofI was engaged in unlawful conduct which would subject the Company to heightened regulatory scrutiny and potential criminal sanctions.
According to the complaint, following a March 31, 2017 article detailing that the Company was the subject of a probe led by the U.S. Department of Justice and involving the U.S. Securities and Exchange Commission and the U.S. Department of Treasury, the value of BofI shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in BofI securities purchased on or after April 28, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
AFT Leaves X Over AI-Generated Images of Minors
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 



